These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 12506199)

  • 1. Positive and negative regulation of APP amyloidogenesis by sumoylation.
    Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins.
    Dorval V; Mazzella MJ; Mathews PM; Hay RT; Fraser PE
    Biochem J; 2007 Jun; 404(2):309-16. PubMed ID: 17346237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO-1 modification increases human SOD1 stability and aggregation.
    Fei E; Jia N; Yan M; Ying Z; Sun Q; Wang H; Zhang T; Ma X; Ding H; Yao X; Shi Y; Wang G
    Biochem Biophys Res Commun; 2006 Aug; 347(2):406-12. PubMed ID: 16828461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
    Wagner T; Godmann M; Heinzel T
    Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
    Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
    Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
    McMillan LE; Brown JT; Henley JM; Cimarosti H
    Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels.
    Zhang YQ; Sarge KD
    Biochem Biophys Res Commun; 2008 Oct; 374(4):673-8. PubMed ID: 18675254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.
    Owerbach D; McKay EM; Yeh ET; Gabbay KH; Bohren KM
    Biochem Biophys Res Commun; 2005 Nov; 337(2):517-20. PubMed ID: 16198310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
    Marcos-Villar L; Campagna M; Lopitz-Otsoa F; Gallego P; González-Santamaría J; González D; Rodriguez MS; Rivas C
    J Gen Virol; 2011 Jan; 92(Pt 1):188-94. PubMed ID: 20881090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
    Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
    J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing and quantifying protein polySUMOylation at the single-molecule level.
    Yang Y; Zhang CY
    Anal Chem; 2014 Jan; 86(2):967-72. PubMed ID: 24383460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.